New England Biotech Association Elects New President

Monday, March 15, 2010 General News J E 4

CAMBRIDGE, Mass., March 15 The New England Biotech Association (NEBA) elected Paul Pescatello President of the organization for 2010 at their annual meeting.

Pescatello has been a member of NEBA's board since the group's founding and has played a vital role in the success of the organization. As Director of CURE (Connecticut United for Research Excellence) Pescatello understands the need for cooperation among the states in the region and the benefits of working together.

"NEBA will continue to be a tight knit organization dedicated to facilitating solid working relationships among the New England biotech industries," said Pescatello. "While each state has its own unique challenges, NEBA continues to bring these industries together as a strong, unified group to help foster policy initiatives and protect the industry it serves."

One of the priorities for the coming year will focus on education of the next generation of biotech workers. Said Pescatello, " At this time of economic upheaval, it is crucial to engage and educate our kids in math and science, to help build and keep job opportunities in the biotech and biopharmaceutical industries throughout New England."

NEBA is a non-profit, member-driven organization comprised of state biotech associations, companies, academic institutions, and other organizations with a collective mission to support and grow the biotechnology industry in New England.

With more than 600 members NEBA's core mission is to ensure that New England remains and prospers as a leader in biotechnology and biopharmaceutical industries. NEBA members include the largest biotech associations in those states, including the Biotech Association of Maine, Connecticut United for Research Excellence (CURE), New Hampshire Bio/Medical Council, Rhode Island BioGroup, Massachusetts High Technology Council, and the Biotech Association of Vermont.

To find out more about NEBA, visit

SOURCE New England Biotech Association


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The Marley Family Announces Partnership With HoMed...
PDL BioPharma Announces Conversion Rate Adjustment...